Our Deals
Latest Deals
![Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Tombstone%20Anju%20%2B%20Valsoft.png)
Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities
![Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20LVCCRCNJ%20-%20Social.png)
Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network
![Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20LVCKerwin%20-%20Social.png)
Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network
![Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2.png)
Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe
![Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Myonex%20%2B%20Creapharm-%20Social%20V2%20(1).png)
Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US
![Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Tombstone%20-%20Calyx%20(Social%20Sized).V3-1.png)
Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions
![physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research](https://www.crosstreecapital.com/hubfs/Deal%20Campaign%20Tombstone%20-%20PhysIQ%20(Social%20Sized)%20(1).png)
physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research
![Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Tombstone%20-%20Continuum%20Clinical%20(Social%20Sized).png)
Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities
![Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Tombstone%20-%20Yecuris%20(Social%20Sized)%20(NEW).png)
Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally
![Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering](https://www.crosstreecapital.com/hubfs/Deal%20Insight%20Campaign%20Tombstone%20-%20Modular%20DevicesO2%20Investment%20Partners%20(Social%20Sized).png)
Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering
![Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Alpha-IRBSabai-Global-Social-Sized.png)
Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities
![Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Campaign-Tombstone-Versiti-Pearl-Pathways-1.png)
Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities
![VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-VaxTRIALS-w-Background.png)
VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities
![Grant Avenue Capital Recapitalizes CREO](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Grant-AvenueCREO-with-background.png)
Grant Avenue Capital Recapitalizes CREO
![Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Monroe-Biomedical-Research-with-background.png)
Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform
![SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-SSI-Strategy-NDA-Group-AB-with-background.png)
SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU
![Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-Catalyst-Clinical-Research-2.png)
Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings
![Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network and Clinical Trial Execution Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/Deal-Insight-Campaign-Tombstone-AccelAlcanza-w-background.png)
Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network and Clinical Trial Execution Capabilities
![Benchmark Research Acquired by IQVIA, combined with Avacare to Expand Vaccine and Clinical Trial Site Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/BenchmarkIQVIA.jpg)
Benchmark Research Acquired by IQVIA, combined with Avacare to Expand Vaccine and Clinical Trial Site Capabilities
![Clinical Site Services and Patient Advertising Guru Acquired by American Clinical Research Services to Add Tech-Enabled Patient Recruitment Capabilities](https://www.crosstreecapital.com/hubfs/theme-crosstree/deals/CSSi-ACRS_2019-MMD-ICON.jpg)